CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies
2016 ◽
Vol 34
(15_suppl)
◽
pp. e15054-e15054
2009 ◽
pp. 285-293